早期下午的免疫疗法通过配合环形节奏,促进小细胞肺癌患者的生存。 Early afternoon immunotherapy boosts survival in small cell lung cancer patients by aligning with circadian rhythms.

一项新的研究发现,在下午3点前为广泛的小细胞肺癌提供免疫疗法,可大大改善存活率,病人的累进风险降低52%,死亡风险比以后的治疗低63%。 A new study finds that giving immunotherapy for extensive-stage small cell lung cancer before 3:00 p.m. significantly improves survival, with patients facing a 52% lower risk of progression and 63% lower risk of death compared to later treatments. 研究人员对中国397名病人进行了分析,将早期治疗与更好的结果联系起来,这很可能是由于身体的心律节奏影响免疫反应。 Analyzing 397 patients in China, researchers link earlier treatment to better outcomes, likely due to the body’s circadian rhythm influencing immune response. 低成本、简单的计时调整可以加强全世界的护理。 The low-cost, simple timing adjustment could enhance care worldwide.